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serum calcium. Restriction of calcium and vitamin D supple-
ments is sometimes all that is required, although intravenous
fluids may be used for more rapid normalisation of serum
levels. A variety of other treatments have been used: ketocona-
zole, hydroxychloroquine, bisphosphanates and corticosteroids
[6, 8, 17]. The mechanisms for these therapeutic measures are
not fully understood, although corticosteroids are believed to
reduce the concentration of 1,25(OH)2D3 by inhibiting hydro-
xylation to this metabolite [16]. Unless absolutely necessary,
polypharmacy should be avoided as patients already have a
significant medication burden and additional medications may
affect compliance. In our case supplement restriction and
intravenous hydration was sufficient.
Our case illustrates the infrequently recognised and poorly
understood phenomenon of hypercalcaemia in TB. Children
with TB are increasingly being tested and treated for vitamin D
deficiency. However, there are no clear guidelines for dosage
and duration of supplementation, and further studies are
needed to address this. It is therefore important to monitor
serum calcium and vitamin D levels especially after starting
concurrent supplementation and nutrition, and to have a high
index of suspicion for hypercalcaemia when presented with
gastrointestinal or musculoskeletal symptoms.
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A 69-year-old female with multiple, bilateral pulmonary
nodules
To the Editor:
A 69-yr-old post-menopausal female with pulmonary nodules
and a diagnosis of lymphangioleiomyomatosis (LAM) confirmed
elsewhere was referred to our centre (U.O. di Pneumologia,
Ospedale San Giuseppe, Milan, Italy) for further evaluation.
The patient was a nonsmoker and denied any occupational
exposures. There was no family history of cancer. She had no
history of pulmonary diseases or respiratory symptoms. Her past
medical history included systemic hypertension treated with
angiotensin converting enzyme inhibitor, hypercholesterolemia
treated with atorvastatin, and diabetes mellitus. The patient had
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been well until July 2008 when she was evaluated in another
hospital and a breast carcinoma was discovered. Multiple
bilateral small nodules of the lung were noted on a chest
computed tomography performed at the time of breast carcinoma
diagnosis (figs 1 and 2). Fluorodeoxyglucose-positron emission
tomography did not disclose pathological uptake of the lung
nodules. A wedge resection of the lung was performed. The
histological diagnosis was LAM. In October 2008 the patient
underwent breast conserving surgery (quadrantectomy) with
excision of the lesion in the right breast; the pathological
diagnosis was infiltrating ductal carcinoma. She was started on
tamoxifen treatment.
The patient was evaluated in our department in March 2009. She
was completely asymptomatic with no complaints of shortness of
breath, cough, chest pain, fever, chills, night sweats or systemic
symptoms. On examination the patient appeared well and her
vital signs were normal. Pulmonary and general physical
examination was normal. Laboratory tests were all in the normal
range. The results of pulmonary function studies (lung volumes
and diffusing capacity of the lung for carbon monoxide) were
normal. Because a previous diagnosis of LAM had been made, a
magnetic resonance imaging scan of the brain and abdomen was
performed and meningiomas and renal angiomyolipomas were
excluded. Lung computed tomography re-evaluation confirmed
the presence of bilateral nodules, radiological aspects not
characteristic for LAM. A pathological revision of the pulmonary
biopsy was performed and revealed a proliferation of bland
spindle cells surrounding benign entrapped bronchioloalveolar
epithelium (figs 3 and 4). Immunohistochemically, the spindle
cells were positive for desmin and smooth-muscle actin, and
negative for HMB-45. Immunoreactivity for both oestrogen and
FIGURE 1. Chest computed tomography scan showing multiple, bilateral,
well-circumscribed pulmonary nodules.
FIGURE 2. Another chest computed tomography scan showing multiple,
bilateral, well-circumscribed pulmonary nodules.
FIGURE 3. Low-power photomicrograph (haematoxylin–eosin stain) of a lung
biopsy showing a well-circumscribed nodule; partially solid and partially cystic
(upper part). Magnification: 20x.
FIGURE 4. High-power photomicrograph (haematoxylin–eosin stain) of a
pulmonary nodule in lung biopsy showing bland appearing smooth muscle
proliferation with entrapped bronchiolar epithelium. Magnification: 200x. c
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progesterone receptors was present in the smooth muscle
component. Based on these findings, pulmonary benign metas-
tasising leiomyoma (BML) was diagnosed.
A gynaecological examination was performed and multiple uter-
ine leiomyomas were found. A clinical-functional-radiological
follow-up was planned. No further treatment was prescribed and
the residual nodules have not increased in size during the
18 months of follow-up. The patient remains well and without
pulmonary symptoms.
The aetiology of multiple pulmonary nodules is quite complex,
with metastatic disease being the most common cause. Other
possibilities include sarcoidosis or an inflammatory process,
such as fungus, tuberculosis, nocardiosis or septic emboli.
However, in asymptomatic patients, further considerations
include the presence of rheumatoid nodules, amyloidosis
and arteriovenous malformations. The possibility of even less
common lesions, including hamartomas and smooth muscle
tumours such as leiomyomas, also exists [1]. BML is a rare
disorder with ,100 cases reported in the literature. It affects
females who have previously undergone hysterectomies or
myomectomies due to histologically benign-appearing uterine
leiomyomas. Sometimes uterine leiomyoma may be discovered
after pulmonary nodules or other extra-uterine lesions [2, 3].
Although leiomyomas are histologically benign, they can
metastasise to distant sites, such as lungs, skin, bones, media-
stinum, lymph nodes, muscular tissue, heart and retroperito-
neum [4]. The lung is the most common site of involvement.
It appears that the tumour metastasises to lungs and other
extra-uterine tissues via haematogenous spread [3].
Patients with pulmonary BML are almost always asympto-
matic and, as in this case, the radiographic findings are an
incidental finding. The radiographic manifestations are usually
well-defined nodules ranging in size from 0.2 to 8 cm which
may be unilateral or bilateral, scattered among normal inter-
stitium. Typically these nodules are non-calcified and do not
enhance with intravenous contrast administration. Pulmonary
nodules usually show little change and may even sponta-
neously regress. Pathologically, pulmonary BML are com-
posed of benign smooth muscle cells that are similar to uterine
leiomyoma [5]. In addition, the pulmonary nodules contain
glandular appearing structures that have been shown histolo-
gically to consist of alveolar or bronchiolar epithelium. These
entrapped epithelial elements are commonly observed in the
periphery of the metastatic nodules and, sometimes, can be
prominent, causing diagnostic confusion [6]. The clinical
course of patients with BML varies and seems to depend on
the oestrogen status. BML is usually indolent in post-meno-
pausal females, whereas disease progression has been reported
in pre-menopausal females [1, 2]. In addition, the effects of
natural hormonal changes in females (pregnancy and meno-
pause) on tumour growth have been described previously
[7, 8]. Although there have been reports of patient morbidity
and mortality from BML, the clinical course is typically
indolent, with patient mortality commonly due to an unrelated
disease process. There is no standardised treatment for BML
because of the limited number of reported cases. Reported
treatment methods include careful observation, surgical resec-
tion of pulmonary nodules, hysterectomy and bilateral oophor-
ectomy, progesterone, and medical castration using luteinising
hormone-releasing hormone analogue [9]. The pathogenesis of
BML has been a subject of some controversy over the years. Most
pathologists now accept these lesions as haematogenous metas-
tases from morphologically benign uterine tumours, although
there is a continuum with lesions that show increased mitotic
activity. There has been much debate on the true nature of this
lesion, a tumour with benign histological features but having
biological behaviour suggesting malignancy [10–12]. The differ-
ential diagnosis of BML should include metastatic leiomyo-
sarcoma. However, there is still controversy as to where the line
between benign and malignant smooth muscle tumour should
be drawn histologically. Further research into the basic biology
of this neoplasm might reveal that uterine leiomyoma which
gives rise to BML is a different subtype to those that do not
‘‘metastasise’’ [10–12]. BML should not be confused with LAM;
they are distinct entities. LAM is characterised by the prolifera-
tion of smooth muscle cells from lymphatic walls in the lung and
lymph nodes. Young females can present with a spontaneous
pneumothorax, chylous pleural effusion or progressive dys-
pnoea. Characteristic imaging findings include hyperinflation
and numerous thin-walled cystic spaces. The histological dis-
tinction between these two diseases may be difficult in some
cases, however, but clinical and radiographic correlation should
help establish the correct diagnosis.
Although it is a rare condition, BML should be considered in
females with solitary or multiple pulmonary nodules.
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Successful stenting of anastomotic stenosis of the left
pulmonary artery after single lung transplantation
To the Editor:
Lung transplantation is an established therapy for a variety of
end-stage lung diseases. Successful transplantation improves
prognosis and quality of life in most recipients. In the current
setting where lung donors are scarce, single-lung transplanta-
tion allows for more extensive utilisation of the limited donor
organ pool [1]. Although forced expiratory volume in 1 s
(FEV1) recovery is lower and the risk of bronchiolitis obliterans
syndrome is higher, single lung transplant recipients still have
comparable exercise tolerance and quality-of-life scores when
compared to bilateral lung transplant recipients [2].
Fortunately, vascular anastomotic stenoses are an uncommon
event following lung transplantation. There are two types of
vascular complications: either pulmonary arterial stenosis or
pulmonary venous stenosis. The structures affected determine
the clinical manifestations: arterial obstruction leads to pulmon-
ary ischaemia and infarction, and venous obstruction leads to
pulmonary oedema. The diagnosis should be considered in the
presence of unexplained exertional hypoxaemia and persistent
pulmonary hypertension. The diagnosis can be confirmed with
computed tomography pulmonary angiogram (CTPA) and
pulmonary angiography. As the complication is rare there are
no clear treatment algorithms. In the very early phase (1 week),
a) b)
FIGURE 1. Pre-transplant a) chest radiograph and b) perfusion scan. c
EUROPEAN RESPIRATORY REVIEW VOLUME 20 NUMBER 119 59
